Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmaco-Scintigraphic Study of TP05 (Mesalazine) in Healthy Subjects
NCT02306798Phase 1Completed
- Sponsor
- Tillotts Pharma AG
- Start
- Sep 2013
- Primary completion
- Nov 2013
- Modality
- Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of Salcrozine in ulcerative colitis (UC), sponsored by Tillotts Pharma AG. Primary endpoint: Tablet release profile at 3 days. Started Sep 2013; status: completed.
02
Drugs
Salcrozine
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT02306798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02306798.